Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer | Business Wire
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021 | Business Wire
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. — Duke OTC
Aerie Pharmaceuticals and Ramot at Tel Aviv University Enter Research Collaboration | Business Wire
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
Aerie Pharmaceuticals | LinkedIn
Aerie Pharmaceuticals | Capital Sign Solutions
Alcon set to acquire Aerie Pharmaceuticals
Aerie Pharmaceuticals | LinkedIn
Aerie Pharmaceuticals to expand R&D operations in Research Triangle Park - Triangle Business Journal
Aerie Pharma to use DSM polymers to develop eye drug delivery tech
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening its Ophthalmic Pharmaceutical Portfolio
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results | Business Wire
AERIE PHARMACEUTICALS, INC. 2022 NPS
Durham-based Aerie Pharma is sold to global eye care giant in deal worth $770M - Research Triangle Regional Partnership
Aerie Pharmaceuticals changes HQ to Durham, giving the Triangle another public company - Triangle Business Journal